Hola,
Are you new here?

I have an account

Conecta con

+150K Projects

+300K Companies

+230 Financiaciones

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

Infarnosys

financed

Closed

Novel biomarker diagnostic system for the assessment of the prognosis of acute m...

Novel biomarker diagnostic system for the assessment of the prognosis of acute myocardial ischemia reperfusion injury and infarction and the effectiveness of the treatment The Infarnosys project aims to launch a novel, combined biomarker diagnostic system on the market that will help clinicians and laboratories to earlier and better diagnose cardiac ischemia/reperfusion injury and prognosticate the... see more

29/02/2016

PHARMAHUNG

71K€

Project Budget: 71K€

Project leader

PHARMAHUNGARY 2000 KISERLETES ES KLINIKAI KUT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2016-02-29

PHC-12-2015-1: Clinical research for the validatio... Scope:

I+D

Cerrada does 10 years

0% 70% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

PHARMAHUNG

50.00K€ | Leader

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 5 months Date Start: 2015-09-07
End date: 2016-02-29

Project leader

PHARMAHUNGARY 2000 KISERLETES ES KLINIKAI KUT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 71K€

participation deadline Sin fecha límite de participación.

Project description The Infarnosys project aims to launch a novel, combined biomarker diagnostic system on the market that will help clinicians and laboratories to earlier and better diagnose cardiac ischemia/reperfusion injury and prognosticate the effectiveness of the treatment. The innovative process measures MMP-2, MMP-9 and nitrotyrosin levels and tests MMP inhibitors in artery blood samples. Measuring MMP and nitrotyrosin levels enables predicting the occurrence of heart attack and helps to start the treatment much earlier. Testing MMP inhibitors on blood samples will help cardiologists to specify the treatments in a more sophisticated way. For both men and women, coronary artery disease is the leading cause of death in Europe in spite of the fact that 80% of premature heart diseases are preventable. Earlier and better diagnosis of cardiac ischemia and reperfusion injury is crucial for reducing the number of deaths connected to cardiovascular diseases. Our diagnostic marker combination has been tested already in a pre-clinical study and the results were published in the European Journal of Clinical Investigation. A Phase 2 project would aim a clinical trial and the Phase 1 feasibility study would prepare it by performing a market research including a market launch strategy and cost analysis, as well as it would prepare the clinical study documentation and the patenting process.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers

What is innovating.Works? Lose yourself in the best search engine for innovative companies you've ever seen, see how your competition is funded, connect with that partner you didn't know about, discover R&D projects that need you, and much, much more just a click away.

Smart Company-Financial Motor Innovating tiene un perfil tecnológico financiero de 400.000 empresas gracias al cual sabe a qué ayuda puede ir o no cualquier empresa de forma automática. Parece magia pero es tecnología.

Create your project and find partners ¿Tienes un proyecto y buscas un partner? Una Universidad, Centro Tecnológico, Consultoría? Este es tu sitio. Gracias al motor de búsqueda podemos recomendarte los mejores socios y ponerte en contacto con ellos.